LCapital founded by Jonathan Leitersdorf, is a multi-faceted capital group funding Architecture, Leisure, and Techonology ventures.
Investment Type: Venture Capital
Mentions in press and media 5
Date | Title | Description |
19.07.2011 | L Capital adquiere una participación accionarial en el grupo TWC L’Amy | 19/07/2011 Nota de Prensa L CAPITAL ADQUIERE UNA PARTICIPACIÓN ACCIONARIAL EN EL GRUPO TWC L’AMY. L Capital ha firmado un acuerdo de compraventa de una participación en el Grupo TWC L’Amy, que está sujeto a la aprobación de las autoridad... |
13.08.2010 | CeNeRx BioPharma raises $13M for trial of antidepression drug | TriRima works by elevating the levels of three key neurotransmitters that positively affect mood and anxiety, compared to the one or two neurotransmitters addressed by most current antidepressant drugs, according to the company. CeNeRx rece... |
17.04.2009 | iScience sees $20.5M for eye surgery instruments | iScience Interventional, maker of surgical tools for eye operations, has closed a prolonged sixth round of funding at $20.5 million after facing a bit more of a challenge due to the economic climate. The money will be used to commercialize ... |
17.10.2008 | CeNeRx takes $15M to fight depression | CeNeRx BioPharma recently raised $15 million in a second round of funding contributed by Aisling Capital, L Capital Partners and Pappas Ventures. The Cary, N.C. company specializes in treatments for central nervous system disorders. It plan... |
- | CeNeRx BioPharma raises $13M for trial of antidepression drug | CeNeRx BioPharma has raised a $13 million Series C round of financing that will fund phase 2 clinical trials of its antidepressant drug candidate. The phase 2 trial is the next step in a lengthy process that the company hopes results in get... |